Collaborative oncology drugs review initiative announced by FDA
A new initiative has already collaboratively reviewed applications for two oncology drugs, allowing for simultaneous decisions in three countries.
List view / Grid view
A new initiative has already collaboratively reviewed applications for two oncology drugs, allowing for simultaneous decisions in three countries.
Health Canada has published new guidance for manufacturers of higher-risk 3D-printed medical devices.
Previously unpublished information from the clinical trial that the FDA relied on to approve the most commonly prescribed medicine for nausea in pregnancy indicates the drug is not effective...
Health Canada has approved Ozempic to improve glycemic control in adults with type 2 diabetes mellitus when metformin is not tolerated or contraindicated...